---
title: Syngene International vs WuXi AppTec
slug_a: syngeneintl
slug_b: wuxiapptec
site: cro
review_signal_gate: closed
canonical_path: /compare/syngeneintl/wuxiapptec
generated_by: BioBM Editorial AI
---

# Syngene International vs WuXi AppTec

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Syngene International (syngeneintl) is listed for both. Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.

Services: 100. Modalities: 10. Indications: 14. Locations: 3. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (100).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

WuXi AppTec (wuxiapptec) is listed for cro. Global CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.

Services: 41. Modalities: 10. Indications: 14. Locations: 2. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (41).

Review summary: Review summary withheld until site-level review gate opens.